Back to search

Soluble interleukin 2 receptor in atopic eczema.

Data up to Jan 2025

Published1989
Citations78
References28

Total Citations Per Year

Abstract

References (28)

Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.

1985 • 1,143 citations

Interleukin-2 augments natural killer cell activity

1981 • 921 citations

Triggering of the T3-Ti antigen-receptor complex results in clonal T-cell proliferation through an interleukin 2-dependent autocrine pathway.

1984 • 506 citations

The interleukin 2 receptor. Functional consequences of its bimolecular structure.

1987 • 409 citations

Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cells

1984 • 375 citations

Cyclosporin A and dexamethasone suppress T cell responses by selectively acting at distinct sites of the triggering process.

1980 • 351 citations

The released interleukin 2 receptor binds interleukin 2 efficiently.

1986 • 348 citations

Recombinant interleukin-2 directly augments the cytotoxicity of human monocytes

1987 • 301 citations

Immunoglobulin E in Dermatoses

1969 • 298 citations

Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition.

1988 • 274 citations

Characterization of the human receptor for T-cell growth factor.

1983 • 240 citations

Depression of cell-mediated immunity in atopic eczema

1975 • 196 citations

Effect of cyclosporin A and dexamethasone on interleukin 2 receptor gene expression.

1986 • 171 citations

Soluble interleukin‐2 receptors in systemic lupus erythematosus

1988 • 170 citations

Structure-function relationships for the IL 2-receptor system. IV. Analysis of the sequence and ligand-binding properties of soluble Tac protein.

1987 • 165 citations

Flow cytometric resonance energy transfer measurements support the association of a 95-kDa peptide termed T27 with the 55-kDa Tac peptide.

1987 • 99 citations

Serum interleukin-2-receptor in rheumatoid arthritis: A prognostic indicator of disease activity?

1988 • 85 citations

Quantitative analysis of T-lymphocyte subsets in atopic eczema, using monoclonal antibodies and flow cytoafluorimetry

1983 • 65 citations

Predominance of T lymphocytes in the dermal infiltrate of atopic dermatitis

1979 • 65 citations

Immune status in atopic eczema: a survey

1979 • 63 citations

Interleukin 2 synthesis in the presence of steroids: a model of steroid resistance.

1987 • 58 citations

Corticosteroid-interleukin 2 interactions: inhibition of binding of interleukin 2 to interleukin 2 receptors.

1987 • 49 citations

Interleukin 2 receptor in patients with localized and systemic parasitic diseases.

1988 • 46 citations

Humoral and cellular immunity in children with active and quiescent atopic dermatitis

1987 • 32 citations

Interleukin 2 functions through novel interleukin 2 binding molecules in T cells.

1988 • 30 citations

Studies on hyperimmunoglobulinaemia E in atopic diseases with particular reference to food allergens.

1981 • 24 citations

Suppression of the local graft‐vs.‐host reaction in ratsby treatment with a monoclonal antibody specific for the interleukin 2 receptor

1986 • 18 citations

Determination of cell-free interleukin 2 receptor level in the serum of normal animals and of animals bearing IL-2 receptor positive tumours with high or low metastatic capacity

1987 • 13 citations

Cited By (0)

No citing papers found in database

Soluble interleukin 2 receptor in atopic eczema. (1989) – BMJ | Metascience Observatory Explorer